Mylan must face certified EpiPen class action, judge rules

A pharmacy counter with medication on the shelf and pick up board on the top

A federal judge on Thursday said plaintiffs suing Mylan NV for engaging in an allegedly unlawful scheme to squelch competition and sharply raise prices for its EpiPen allergy treatment can proceed as a class.

To read the full story on WestlawNext Practitioner Insights, click here

Be the first to comment

Leave a Reply

Your email address will not be published.


*